IP Library › Granted Patent US 10,415,087
Granted Patent B2
US 10,415,087 · App. 15/630,846 · Granted Sep 17, 2019

Methods for adding adapters to nucleic acids and compositions for practicing the same

Inventors: Craig Betts (Mountain View, CA); Andrew Alan Farmer (Mountain View, CA)
Assignee: TAKARA BIO USA, INC.
C12Q1/6869C12N15/1096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,415,087
App. No.
15/630,846
Granted
Sep 17, 2019
Kind
B2
Abstract

Provided are methods of adding adapters to nucleic acids. The methods include combining in a reaction mixture a template nucleic acid, a template switch oligonucleotide, a polymerase, and dNTPs. The reaction mixture components are combined under conditions sufficient to produce a product nucleic acid that includes the template nucleic acid and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid including a region polymerized from the dNTPs by the polymerase. The methods further include attaching sequencing platform adapter constructs to ends of the product nucleic acid or a derivative thereof. Aspects of the invention further include compositions and kits.

Claims (31)

1. A kit comprising:

a template switch oligonucleotide comprising a 3′ hybridization domain and one or more exo-sample nucleotides 5′ of the 3′ hybridization domain;

a sequencing platform adapter construct; and

a template switching polymerase.

2. The kit of claim 1 , wherein the sequencing platform adapter construct comprises a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

3. The kit of claim 1 , comprising a first-strand synthesis primer comprising a first domain that hybridizes to a template nucleic acid and a second domain that does not hybridize to the template RNA.

4. The kit of claim 3 , wherein the second domain comprises a sequencing platform adapter construct comprising a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

5. The kit of claim 1 , wherein the template switching polymerase is a reverse transcriptase.

6. The kit of claim 1 , wherein the exo-sample nucleotides comprise a ribonucleotide.

7. The kit of claim 6 , wherein the ribonucleotide is cleavable by a ribonuclease.

8. The kit of claim 1 , wherein the exo-sample nucleotides comprise a deoxyuridine.

9. The kit of claim 8 , wherein the deoxyuridine is cleavable by a uracil-N-glycosylase.

10. The kit of claim 1 , wherein the exo-sample nucleotides comprise a nucleotide selected from the group consisting of: bromodeoxyuridine, 7-methylguanine, 5,6-dihydroxydeoxythymidine, 3-methyldeoxyadenosine, and any combination thereof.

11. A kit comprising:

a template switch oligonucleotide comprising a 3′ hybridization domain and one or more ribonucleotides 5′ of the 3′ hybridization domain;

a sequencing platform adapter construct;

a template switching polymerase; and

a ribonuclease.

12. The kit of claim 11 , wherein the template switch oligonucleotide comprises two or more ribonucleotides 5′ of the 3′ hybridization domain.

13. The kit of claim 11 , wherein the sequencing platform adapter construct comprises a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

14. The kit of claim 11 , comprising a first-strand synthesis primer comprising a first domain that hybridizes to a template nucleic acid and a second domain that does not hybridize to the template nucleic acid.

15. The kit of claim 14 , wherein the second domain comprises a sequencing platform adapter construct comprising a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

16. A kit comprising:

a template switch oligonucleotide comprising a 3′ hybridization domain and one or more exo-sample nucleotides selected from the group consisting of: bromodeoxyuridine, 7-methylguanine, 5,6-dihydroxydeoxythymidine, and 3-methyldeoxyadenosine, or any combination thereof;

a sequencing platform adapter construct;

a template switching polymerase; and

an enzyme for degrading a portion of the template switch oligonucleotide that is 5′ of the 3′ hybridization domain.

17. The kit of claim 16 , wherein the enzyme is selected from the group consisting of: a uracil-N-glycosylase, a lyase, a DNA glycosylase-lyase and combinations thereof.

18. The kit of claim 16 , wherein the sequencing platform adapter construct comprises a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

19. The kit of claim 16 , comprising a first-strand synthesis primer comprising a first domain that hybridizes to a template nucleic acid and a second domain that does not hybridize to the template nucleic acid.

20. The kit of claim 19 , wherein the second domain comprises a sequencing platform adapter construct comprising a nucleic acid domain selected from the group consisting of: a domain that specifically binds to a surface-attached sequencing platform oligonucleotide, a sequencing primer binding domain, a barcode domain, a barcode sequencing primer binding domain, a molecular identification domain, a complement of any such domains, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2017
From: BETTS, CRAIG; FARMER, ANDREW ALAN
To: CLONTECH LABORATORIES, INC.
Reel/Frame 043196/0969 →
CHANGE OF NAME Recorded Aug 4, 2017
From: CLONTECH LABORATORIES, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 043197/0038 →
Continuity (4)
Continuation 14566445 · Dec 10, 2014
Provisional Application 61917101 · Dec 17, 2013
Provisional Application 61979856 · Apr 15, 2014
Related Publication 20170327882A1 · Nov 16, 2017